Relationship Between Lymphocyte Count and Risk Of Infection In Rheumatoid Arthritis Patients Treated With Tofacitinib

被引：0
作者：
Van Vollenhoven, R. F. [1 ]
Riese, R. [2 ]
Krishnaswami, S. [2 ]
Kawabata, T. [2 ]
Fosser, C. [2 ]
Rottinghaus, S. [2 ]
Lamba, M. [2 ]
Zwillich, S. H. [2 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Pfizer Inc, Groton, CT 06340 USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2330
引用
收藏
页码：S994 / S994
页数：1
相关论文
共 50 条
  • [11] Assessment of lipid changes and infection risk in diabetic and nondiabetic patients with rheumatoid arthritis treated with tofacitinib.
    Rigby, W.
    Takiya, L.
    Wood, S.
    Fan, H.
    Jones, T.
    PHARMACOTHERAPY, 2014, 34 (10): : E224 - E224
  • [12] Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care
    Riek, Myriam
    Scherer, Almut
    Moeller, Burkhard
    Ciurea, Adrian
    von Muehlenen, Ines
    Gabay, Cem
    Kyburz, Diego
    Brulhart, Laure
    von Kempis, Johannes
    Mueller, Ruediger B.
    Hasler, Paul
    Strahm, Tanja
    von Kaenel, Sabine
    Zufferey, Pascal
    Dudler, Jean
    Finckh, Axel
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [13] ENDOTHELIAL INFLAMMATION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB
    Delavega, M.
    Peon, C.
    Rodriguez, G.
    Benavidez, F.
    Benitez, A.
    Gamba, M. J.
    Eleta, M.
    Riopedre, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 610 - 610
  • [14] The Relationship Between Red Cell Distribution Width, Absolute Lymphocyte Count, and Rheumatoid Arthritis
    Wang, Gang
    Liu, Zhichun
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (10) : 1355 - 1355
  • [15] Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
    Francesca Romana Spinelli
    Cristina Garufi
    Silvia Mancuso
    Fulvia Ceccarelli
    Simona Truglia
    Fabrizio Conti
    Scientific Reports, 13 (1)
  • [16] Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
    Spinelli, Francesca Romana
    Garufi, Cristina
    Mancuso, Silvia
    Ceccarelli, Fulvia
    Truglia, Simona
    Conti, Fabrizio
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [17] Infection risk in patients with rheumatoid arthritis treated with etanercept or adalimumab
    Chiang, Yi-Chun
    Kuo, Li-Na
    Yen, Yu-Hsuan
    Tang, Chao-Hsiun
    Chen, Hsiang-Yin
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2014, 116 (03) : 319 - 327
  • [18] INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB
    Vanesa Bejarano, Marisel
    Natalia Tamborenea, Maria
    Goni, Mario
    Saldarriaga, Lina
    Pisoni, Cecilia
    Garcia Salinas, Rodrigo
    Salcedo, Mariana
    Helling, Claudia
    Salas, Adrian
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 12 - 13
  • [19] INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB
    Bejarano, Marisel
    Natalia Tamborenea, Maria
    Alberto Goni, Mario
    Saldarriaga, Lina
    Pisoni, Cecilia
    Garcia Salinas, Rodrigo
    Salcedo, Mariana
    Helling, Claudia
    Salas, Adrian
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1672 - 1672
  • [20] Serious infection with tofacitinib in patients with rheumatoid arthritis: the importance of context
    Rivas, Jose L.
    Jones, Thomas
    Connell, Carol A.
    LANCET RHEUMATOLOGY, 2020, 2 (12) : E738 - E738
12345